OTC Cough/Cold Product Recalled Due to Mislabeling

Pfizer advise distribution to be ceased immediately if in possession of the recalled lots
Pfizer advise distribution to be ceased immediately if in possession of the recalled lots

Pfizer Consumer Healthcare announced a voluntary recall of one lot of Adult Robitussin Peak Cold Cough + Chest Congestion DM due to some bottles being mislabeled as Adult Robitussin Maximum Strength Nighttime Cough DM. 

The affected products have Lot # R29364 with an expiration date of 10/17. They are supplied in cartons containing one 8 floz (237mL) bottle. If in possession of the recalled product, the company stated to cease distribution immediately and arrange for return to Stericycle. 

RELATED: ACP, CDC Advise on Antibiotic Prescribing for Acute RTI

Robitussin Peak Cold Cough + Chest Congestion DM (dextromethorphan HBr, guaifenesin) is indicated for temporary relief of minor throat and bronchial irritation that may occur with a cold, and to help loosen mucus and thin bronchial secretions to train bronchial tubes. Robitussin Maximum Strength Nighttime Cough DM syrup (dextromethorphan HBr, doxylamine succinate) is indicated for the temporary relief of cough due to minor throat and bronchial irritation and for the temporary relief of symptoms of hay fever or other upper respiratory allergies. 

The company stated that consumption of this product is not likely to cause adverse health effects. 

For more information call (800) 762-4675 or visit Pfizer.com.

Loading links....